Clinical Use of Continuous Glucose Monitoring in Adults with Type 2 Diabetes
- 1 May 2017
- journal article
- research article
- Published by Mary Ann Liebert Inc in Diabetes Technology & Therapeutics
- Vol. 19 (S2), S4-4
- https://doi.org/10.1089/dia.2017.0024
Abstract
Background: Hemoglobin A1c is an excellent population health measure for the risk of vascular complications in diabetes, while continuous glucose monitoring (CGM) is a tool to help personalize a diabetes treatment plan. The value of CGM in individuals with type 1 diabetes (T1D) has been well demonstrated when compared with utilizing self-monitoring of blood glucose (SMBG) to guide treatment decisions. CGM is a tool for patients and clinicians to visualize the important role that diet, exercise, stress management, and the appropriate selection of diabetes medications can have in managing type 2 diabetes (T2D). Several diabetes organizations have recently reviewed the literature on the appropriate use of CGM in diabetes management and concluded CGM may be a useful educational and management tool particularly for patients on insulin therapy. The indications for using CGM either as a clinic-based loaner distribution model for intermittent use (professional CGM) or a CGM system owned by the patient and used at home with real-time glucose reading (personal CGM) are only beginning to be addressed in T2D. Most summaries of CGM studies conclude that having a standardized glucose pattern report, such as the ambulatory glucose profile (AGP) report, should help facilitate effective shared decision-making sessions. The future of CGM indications for the use of CGM is evolving rapidly. In some instances, CGM is now approved for making medication adjustments without SMBG confirmation and it appears that some forms of CGM will be approved for use in the Medicare population in the United States in the near future. Many individuals with T1D and T2D and their care teams will come to depend on CGM as a key tool for diabetes management.Keywords
This publication has 52 references indexed in Scilit:
- Do we need continuous glucose monitoring in type 2 diabetes?Diabetes/Metabolism Research and Reviews, 2013
- Systematic review and meta-analysis of the effectiveness of continuous glucose monitoring (CGM) on glucose control in diabetesDiabetology & Metabolic Syndrome, 2013
- Association between glucose variability as assessed by continuous glucose monitoring (CGM) and diabetic retinopathy in type 1 and type 2 diabetesActa Diabetologica, 2013
- Short- and Long-Term Effects of Real-Time Continuous Glucose Monitoring in Patients With Type 2 DiabetesDiabetes Care, 2011
- Incretins: Clinical Perspectives, Relevance, and Applications for the Primary Care Physician in the Treatment of Patients With Type 2 Diabetes MellitusMayo Clinic Proceedings, 2010
- Use of a real time continuous glucose monitoring system as a motivational device for poorly controlled type 2 diabetesDiabetes Research and Clinical Practice, 2008
- Adjust to Target in Type 2 DiabetesDiabetes Care, 2008
- Continuous glucose monitoring counseling improves physical activity behaviors of individuals with type 2 diabetes: A randomized clinical trialDiabetes Research and Clinical Practice, 2008
- Characterizing Glucose Exposure for Individuals with Normal Glucose Tolerance Using Continuous Glucose Monitoring and Ambulatory Glucose Profile AnalysisDiabetes Technology & Therapeutics, 2008
- Ambulatory Glucose Profile: Representation of Verified Self-Monitored Blood Glucose DataDiabetes Care, 1987